Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Synta Pharmaceuticals Corp

+ Add to Watchlist

SNTA:US

2.3800 USD 0.00000.00%

As of 20:10:00 ET on 03/03/2015.

Snapshot for Synta Pharmaceuticals Corp (SNTA)

Open: 2.3800 Day's Range: 2.3300 - 2.4400 Volume: 484,561
Previous Close: 2.3800 52wk Range: 2.1800 - 6.6000 1-Yr Rtn: -63.10%

Stock Chart for SNTA

No chart data available.
  • SNTA:US 2.3800
  • 1D
  • 1M
  • 1Y
2.3800
Interactive SNTA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SNTA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.0200
Est. EPS (USD) (12/2014) -0.8860
Est. PEG Ratio -
Market Cap (M USD) 259.17
Shares Outstanding (M) 108.90
30 Day Average Volume 770,871
Price/Book (mrq) 3.0954
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SNTA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SNTA

Synta Pharmaceuticals Corp. is a biopharmaceutical company developing small-molecule drugs for inflammatory diseases, cancer, and diabetes. The Company has drug candidates in human clinical trials and additional programs in preclinical studies.

Anne C WhitakerPresident/CEOChen SchorExec VP/COO
Marc R SchneebaumSenior VP/CFOVojo VukovicSenior VP/Chief Medical Ofcr
More Company Profile & Key Executives for SNTA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil